Cargando…
A Phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer
The primary objective of this study was to determine the response rates of the gemcitabine and cisplatin combination in unresectable gall bladder cancer patients. The secondary objectives were to evaluate the toxicity, time to progressive disease, and overall survival. Chemonaïve patients with histo...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409709/ https://www.ncbi.nlm.nih.gov/pubmed/15083178 http://dx.doi.org/10.1038/sj.bjc.6601736 |